INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 251 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q4 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $270,229 | -13.6% | 4,707 | -15.6% | 0.00% | 0.0% |
Q4 2022 | $312,758 | +44.1% | 5,578 | +8.8% | 0.00% | 0.0% |
Q3 2022 | $217,000 | -21.1% | 5,129 | +0.6% | 0.00% | 0.0% |
Q2 2022 | $275,000 | -41.0% | 5,100 | -29.7% | 0.00% | 0.0% |
Q1 2022 | $466,000 | -17.4% | 7,253 | -13.7% | 0.00% | 0.0% |
Q4 2021 | $564,000 | +22.1% | 8,403 | +24.6% | 0.00% | 0.0% |
Q3 2021 | $462,000 | -14.6% | 6,745 | -15.0% | 0.00% | -50.0% |
Q2 2021 | $541,000 | +15.4% | 7,933 | +16.9% | 0.00% | +100.0% |
Q1 2021 | $469,000 | +6.1% | 6,784 | -0.5% | 0.00% | -50.0% |
Q4 2020 | $442,000 | +56.2% | 6,815 | +13.5% | 0.00% | +100.0% |
Q3 2020 | $283,000 | +4.0% | 6,003 | +3.5% | 0.00% | 0.0% |
Q2 2020 | $272,000 | -39.7% | 5,798 | -25.1% | 0.00% | -50.0% |
Q4 2019 | $451,000 | +7.1% | 7,742 | +10.5% | 0.00% | 0.0% |
Q3 2019 | $421,000 | +2.4% | 7,009 | -4.8% | 0.00% | 0.0% |
Q2 2019 | $411,000 | -15.1% | 7,360 | -15.3% | 0.00% | -33.3% |
Q1 2019 | $484,000 | +58.7% | 8,690 | +28.4% | 0.00% | +50.0% |
Q4 2018 | $305,000 | -44.4% | 6,768 | -18.7% | 0.00% | -50.0% |
Q3 2018 | $549,000 | +10.9% | 8,329 | +8.4% | 0.00% | +33.3% |
Q2 2018 | $495,000 | -23.7% | 7,685 | -34.5% | 0.00% | -25.0% |
Q1 2018 | $649,000 | +3.5% | 11,735 | -10.4% | 0.00% | 0.0% |
Q4 2017 | $627,000 | +74.7% | 13,093 | +84.0% | 0.00% | +33.3% |
Q3 2017 | $359,000 | +3.8% | 7,114 | +12.1% | 0.00% | 0.0% |
Q2 2017 | $346,000 | -1.7% | 6,347 | -24.0% | 0.00% | -25.0% |
Q1 2017 | $352,000 | -25.7% | 8,350 | +51.2% | 0.00% | -20.0% |
Q4 2016 | $474,000 | +60.7% | 5,521 | +54.3% | 0.01% | +25.0% |
Q3 2016 | $295,000 | -15.0% | 3,577 | -17.7% | 0.00% | 0.0% |
Q2 2016 | $347,000 | +24.8% | 4,348 | +5.2% | 0.00% | 0.0% |
Q1 2016 | $278,000 | -15.2% | 4,132 | -14.7% | 0.00% | 0.0% |
Q4 2015 | $328,000 | +31.7% | 4,845 | +31.2% | 0.00% | +33.3% |
Q2 2015 | $249,000 | -26.5% | 3,692 | -32.9% | 0.00% | -25.0% |
Q1 2015 | $339,000 | +5.0% | 5,502 | -7.5% | 0.00% | 0.0% |
Q4 2014 | $323,000 | -38.0% | 5,950 | -43.3% | 0.00% | -42.9% |
Q3 2014 | $521,000 | -15.0% | 10,499 | -19.5% | 0.01% | -12.5% |
Q2 2014 | $613,000 | -43.7% | 13,036 | -44.9% | 0.01% | -42.9% |
Q1 2014 | $1,089,000 | +106.2% | 23,674 | +80.6% | 0.01% | +7.7% |
Q3 2013 | $528,000 | +7.3% | 13,108 | -2.5% | 0.01% | +30.0% |
Q2 2013 | $492,000 | – | 13,442 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |